Filter by: patients
What is Micardis HCT?

Micardis® HCT is a brand name for the combination of telmisartan and hydrochlorothiazide. It is used in the treatment of hypertension. Since it is a combination product it is not recommended for initial therapy.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Elevated blood pressure 12 0
Other 5 4 Efficacy_major Efficacy_moderate Efficacy_slight
Doctor recommendation 1 0
restarted 1 1 Efficacy_major

See all 16 patients currently taking Micardis HCT

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
0
Moderate
1
Mild
0
None
3

Commonly reported side effects, conditions, and hospitalizations associated with Micardis HCT

Swelling 1

Reported Dosages

  daily 12.5 mg-40 mg daily 25 mg-80 mg daily 12.5 mg-80 mg daily 80 mg daily
  1 Number of Patients: 1 8 Number of Patients: 8 2 Number of Patients: 2 3 Number of Patients: 3 2 Number of Patients: 2  

Reported Stop Reasons

Why Patients Stopped Taking Micardis HCT (multiple reasons could be selected)
Reason # Patients Percentage of patients
Expense 2   Expense: 67%
Other 1   Other: 33%
Course of treatment ended 1   Course of treatment ended: 33%

See all 3 patients who’ve stopped taking Micardis HCT

Currently Taking Micardis HCT

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Stopped Taking Micardis HCT

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of Micardis HCT

Always
3 75%
Usually
0 0%
Sometimes
1 25%
Never
0 0%

Burden

Difficulty being on treatment

Burden of Micardis HCT

Very
0 0%
Somewhat
0 0%
A little
1 25%
Not at all
3 75%

Cost

Paid out of pocket

Cost of Micardis HCT

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
1 50%
< $25
1 50%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 25, 2012.